HANWHA SOLUTIONS CORP.

DUBLIN, Dec. 19, 2022 /PRNewswire/ -- The "Global Biosimilars Partnering Terms and Agreements 2010 to 2022" report has been added to ResearchAndMarkets.com's offering. The Global Biosimilars Partnering Terms and Agreements 2010 to 2022 report provides an understanding and access to 190 biosimilars partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter biosimilars partnering deals. The majority of deals are early development stage whereby the licensee obtains a right or an option right to license the licensors biosimilars technology or product candidates. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not. This report contains links to online copies of actual biosimilars deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal. The initial chapters of this report provide an orientation of biosimilars dealmaking and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in biosimilars dealmaking since 2010, including details of average headline, upfront, milestone and royalty terms. Chapter 3 provides a review of the leading biosimilars deals since 2010. Deals are listed by headline value, signed by big pharma, most active biosimilars dealmaking companies. Where the deal has an agreement contract published at the SEC a link provides online access to the contract. Chapter 4 provides a comprehensive listing of the top 25 most active companies in biosimilars dealmaking with a brief summary followed by a comprehensive listing of biosimilars deals, as well as contract documents available in the public domain. Where available, each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand. Chapter 5 provides a comprehensive and detailed review of biosimilars partnering deals signed and announced since Jan 2010, where a contract document is available in the public domain. The chapter is organized by company A-Z, deal type (collaborative R&D, co-promotion, licensing etc), and specific therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand. Chapter 6 provides a comprehensive and detailed review of biosimilars partnering deals signed and announced since Jan 2010. The chapter is organized by specific biosimilars technology type in focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand. In addition, a comprehensive appendix is provided organized by biosimilars partnering company A-Z, deal type definitions and biosimilars partnering agreements example. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand. Analyzing actual company deals and agreements allows assessment of the following: What is actually granted by the agreement to the partner company? What exclusivity is granted? What are the precise rights granted or optioned? What is the payment structure for the deal? How are sales and payments audited? What is the deal term? How are the key terms of the agreement defined? How are IPRs handled and owned? Who is responsible for commercialization? Who is responsible for development, supply, and manufacture? How is confidentiality and publication managed? How are disputes to be resolved? Under what conditions can the deal be terminated? What happens when there is a change of ownership? What sublicensing and subcontracting provisions have been agreed? Which boilerplate clauses does the company insist upon? Which boilerplate clauses appear to differ from partner to partner or deal type to deal type? Which jurisdiction does the company insist upon for agreement law? Global Biosimilars Partnering Terms and Agreements 2010 to 2022 includes: Trends in biosimilars dealmaking in the biopharma industry since 2010 Access to headline, upfront, milestone and royalty data Access to over 190 biosimilars deal records and contract documents where available The leading biosimilar deals by value since 2010 Most active biosimilars dealmakers since 2010 The leading biosimilars partnering resources In Global Biosimilars Partnering Terms and Agreements 2010 to 2022, the available contracts are listed by: Company A-Z Headline value Stage of development at signing Deal component type Specific therapy and technology target Key Topics Covered: Executive Summary Chapter 1 - Introduction Chapter 2 - Trends in biosimilars dealmaking 2.1. Introduction 2.2. Biosimilars partnering over the years 2.3. Most active biosimilars dealmakers 2.4. Biosimilars partnering by deal type 2.5. Biosimilars partnering by therapy area 2.6. Deal terms for biosimilars partnering 2.6.1 Biosimilars partnering headline values 2.6.2 Biosimilars deal upfront payments 2.6.3 Biosimilars deal milestone payments 2.6.4 Biosimilars royalty rates Chapter 3 - Leading biosimilars deals 3.1. Introduction 3.2. Top biosimilars deals by value Chapter 4 - Most active biosimilars dealmakers 4.1. Introduction 4.2. Most active biosimilars dealmakers 4.3. Most active biosimilars partnering company profiles Chapter 5 - Biosimilars contracts dealmaking directory 5.1. Introduction 5.2. Biosimilars contracts dealmaking directory Chapter 6 - Biosimilars dealmaking by technology type Appendices Appendix 1 - Biosimilars deals by company A-Z Appendix 2 - Biosimilars deals by stage of development Appendix 3 - Biosimilars deals by deal type Appendix 4 - Biosimilars deals by therapy area Appendix 5 - Appendix 6 - Recent report titles from Companies Mentioned 3SBio 180 Life Sciences Abbvie Abreos Biosciences Abzena Accord Healthcare Aceno Biotherapeutics AdAlta AET Biotech Aetos Biologics AffaMed Therapeutics Agila Specialties AIT Bioscience Algorithme Pharma Holdings Alteogen Altiora Alvogen Alvotech Amedica Amgen Amneal Pharmaceuticals Arecor Avid Bioservices Axantia Back-A-Line Bacterin International Baxalta Baxter International BeiGene Bio-Manguinhos/Fiocruz Bio-Thera Solutions Biocnd Biocon Bioeq IP Bio Farma Biogen Biooutsource BiosanaPharma BioSavita BioSciencesCorp Bioton BioXpress Boehringer Ingelheim Bolt Biotherapeutics Boston Oncology Bruker C-Bridge Capital Catalent CEA-Leti Celares Celerion Cellectis Celltrion Changchun High & New Technology Industries Chemo Sa Lugano Chungnam National University Cipla CJ Corp Clinigen Cobra Biologics Coherus Biosciences Compass Biotechnologies Concord Biosciences Cook Pharmica CR Pharma Daiichi Sankyo Diabeloop DM Corporation Dong-A ST Dr. Reddy's Laboratories Dyadic International EirGenix EMD Millipore Enzene Biosciences Epirus Biopharmaceuticals Epivax European Commission Evercyte Evotec Ewopharma Formosa Pharmaceuticals Formycon Fujifilm Fujifilm Kyowa Kirin Biologics Fuji Pharma GC Pharma Gedeon Richter GE Healthcare Genentech Genhelix Biopharmaceutical Genor Biopharma GenScript ProBio Gerresheimer Hadasit Medical Research Services and Development Hanwha Chemical Helvetic Biopharma Henlius Biotech Hikma Pharmaceuticals Hoffmann La Roche Horizon 2020 Hospira Innovent Biologics Intas Pharmaceuticals inVentiv Health Ipca Laboratories Ipsen Jacobson Pharma JAMP Pharma Group JHL Biotech Kamada Karolinska Institute Kemwell BioPharma Kymos Pharma Services Kyowa Hakko Kirin Laboratorios Liomont LABORATORIOS SAVAL Ligacept Livzon Mabpharm Lupin M+W Group Mab-Venture Biopharma Mabion mAbXience Medicago Medicure Medipolis Meiji Seika Merck and Co Merck BioVentures Merck KGaA Merck Serono MGC Diagnostics Ministry of Health (Brazil) Mithra Pharmaceuticals Mitsubishi Chemical Mochida Pharmaceutical Momenta Pharmaceuticals Mundipharma Mylan Laboratories Mylan Pharmaceuticals Nan Fung Group NanoLock Natco Pharmaceuticals National Cancer Institute National Comprehensive Cancer Network (NCCN) NCPC GeneTech Neoletix Biotechnology NeuClone Nora Pharma Novo Nordisk Ocumension Therapeutics Oncobiologics ORF Genetics Orox Pharmaceuticals Orygen Biotecnologia Pall Corporation Pangen Biotech Parexel PBS Biotech Perfinity Biosciences Pfenex Pfizer Pharmapark PharmaPraxis PlantForm PlantPraxis Biotecnologia Polpharma Portal Instruments PPD PRA Health Sciences Premier Inc Premier Research Prestige BioPharma ProBioGen PT Etana Biotechnologies Qilu Pharmaceutical Quanta BioDesign QuiaPEG Pharmaceuticals For more information about this report visit Media Contact: Research and Markets Laura Wood, Senior Manager [email protected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Logo: SOURCE Research and Markets

Displays at JEC World 2022 included (top left, clockwise) Hanwha Solutions Neptune CFRP hydrogen storage tank, GBar composite rebar, 3DiTex thermoplastic CFRP bike frame and a motorcycle brake cover using Bcomp flax fiber fabric in an epoxy composite overmolded with CF/PA in a one-shot process using a CONEXUS layer by KTM e-technologies. Photo Credit: CW. More sustainable, automated resin injection Techni-Modul Engineering (Coudes, France) highlighted its automated Smart Injection system for resin transfer molding (RTM) small parts. Resin is directly injected into the mold, infusing dry preforms without conventional tubing, which eliminates these consumables, the waste resin they store and required cleaning. Benefits claimed versus standard injection systems include: 50% labor reduction (15 vs. 30 minutes), 89% consumables reduction (€6 vs. €55) and 80% resin waste reduction (40 vs. 200 grams). Industrialized performance parts production, integrated electronics Biontec (Gallen, Switzerland) designs and manufactures high-performance composites using tailored fiber placement (TFP) and RTM. Production volumes range from 100 to 100,000 parts/year. The company is on its fourth generation of carbon fiber-reinforced polymer (CFRP) bike brake levers and clamps, which use automated stitched preforms that enable reinforced, molded-in holes and 1,200 parts per week. Biontec also showed off a laser scanner drone used for construction sites that features molded-in LEDs, antennas and cables for radar modules and radiolucent composite windows for GNNS antennas, reducing weight and increasing durability and performance. Biontec carbon fiber composite parts for bike lever (left, center) and laser scanner drone (right). Photo Credit: CW Novel automatization for 3D composite tubular/hollow structures 3DiTex (Canéjan, France) is a startup co-founded by Bertrand Laine — previously technical director for RT2i and currently CTO for NOBRAK — together with Aymeric AZRAN (CEO of NOBRAK). Its patented technology reportedly produces multilayer hollow or tubular structures that can be formed into complex shapes as preforms, during molding or thermoformed after consolidation. This technology includes machines capable of continuously producing textiles (>1 meter per minute) as well as algorithms to automate the transformation of CAD object geometry into a machine program with optimized topological trajectories. 3DiTex is targeting thermoplastic composite tapes to dramatically reduce cost, enabling new mass production applications for composites, up to 100,000 parts/year, as well as future use of bio-based matrix and/or fiber materials for improved sustainability. It is also working with other materials like ceramic fiber tapes to produce ceramic matrix composite (CMC) parts. AFP for the masses Carbon Axis (La Rochelle, France) has developed the XCell turnkey automated fiber placement (AFP) cell for SMEs who don’t have robotic skills in-house. Its compact AFP head sits within a temperature- and humidity-controlled cell with a creel below to store the towpreg and slit prepreg tape it uses to create preforms up to 1 x 0.5 x 0.5 meter. The whole system measures 1.6 x 1.6 x 2 meters and can place two 5- to 15-millimeter-wide tows/tapes at minimum lengths with angular cuts (between -45° and +45°) not typically seen in large AFP machines, offering minimized waste and automated, net-shape preforms for small parts manufacturing. The XLay all-in-one software solution integrates part design, layup design, robot simulation and robot coding for a turnkey, reportedly ready- and easy-to-use system, priced at roughly $200,000. See the XCell in action in this March 2022 video. Photo Credit: CW Continuous fiber additive manufacturing of high-volume, high-quality parts 9T Labs Fusion Module demonstrated at JEC World 2022. Photo Credit: CW 9T Labs (Zurich, Switzerland) demonstrated its Build Module and Fusion Module for 3D-printed continuous fiber parts with up to 60% fiber volume and <1% voids. CW’s focus was the Fusion Module, which can apply temperature and pressure up to 400°C and 20 bar, welding multiple printed preforms into single, function-integrated parts with superior surface finish. The system architecture enables connecting sensors for continuous process monitoring and control. The company is developing/preparing to publicize applications in aerospace (interior components, brackets, and engine components), advanced air mobility (rib stiffeners for wings), medical (surgical instruments), luxury (watchmaking, eyewear) and human exoskeletons (ergonomic support for lifting heavy loads). 9T Labs has delivered commercial systems to research centers/universities, aerospace Tier 1 suppliers and the metal forming industry via Setforge, see . Revolutionizing composites repair and production with induction heating Photo Credit: CW Msquare (Stuttgart, Germany) is a spin-off from the German Aerospace Center (DLR) advancing the use of induction heating for composites repair, heated tooling, parts preforming and production. It also offers resistance heating and hot air fan solutions for applications where induction is less optimal, such as in-field repairs to wind blades. On display at JEC were Msqaure’s variety of controllers, including multi-zone hot bonders and compact, smart/multitasking RedZero units. Its FlexIn Heat induction blankets induce eddy currents in thin, metal sheets placed only where heat is needed. Temperatures up to 400°C are applied almost immediately and homogeneously for fast heating and cooling without the need for equilibrium-establishing dwells. FlexinHeat can also be applied to platens and tools, reducing energy use by >50% versus cartridge heaters while dropping cycle times significantly. Watch CW for more about this technology including the September 2022 issue. Thermoplastic composite floor beam for the MFFD Mikrosam (Prilep, Macedonia) showcased a thermoplastic CFRP floorbeam developed in a two-year project with GKN Fokker (Hoogeveen, Netherlands), the project leader for STUNNING (SmarT mUlti-fuNctionNal and INtegrated thermoplastic fuselaGe), which is constructing the lower fuselage section of the all-thermoplastic, 8-meter-long, 4-meter-diameter Clean Sky 2 Multifunctional Fuselage Demonstrator (MFFD). GKN Fokker has installed a Mikrosam eight-axis robotic AFP machine, slitting equipment for thermoplastic prepregs and a custom-engineered thermoplastic consolidating machine. Mikrosam used its in-house systems to demonstrate floor beam production capability to GKN Fokker and produced the parts exhibited at JEC. Watch for more details in CW’s October 2022 issue. Photo Credit: CW Photo Credit: CW Resin infused rudder flap passes the test FiberCore Europe (Rotterdam, Netherlands) displayed a resin infused, glass fiber-reinforced composite rudder flap developed in the RAMSSES project. The 1:6 scale demonstrator was tested successfully to 225% of ultimate design load. The design is aimed at ~400-meter-long container ships and offers 30% weight savings versus steel and double the lifetime. Read more about RAMSSES, the InfraCore helideck and how this technology is helping remove barriers to lightweighting ships. Composite solar cells Photo Credit: CW at JEC World 2022. Porcher Industries (Badinières, France) displayed a composite solar panel developed in collaboration with the French Alternative Energies and Atomic Energy Commission (CEA). The solar cell replaces the heavy and impact-sensitive plate glass front sheet with a glass fiber-reinforced thermoplastic composite layer. Porcher Industries explained in a LinkedIn post that it was challenging to develop a laminate thin and clear enough for solar cells beneath to function effectively. One key was a glass fiber treatment for improved adhesion with the thermoplastic matrix. Targeted benefits include reduced cost and weight and increased impact resistance to enable a wider range of renewable solar energy applications. JEC World 2022 preview: Porcher Industries “Puzzle-cut” SAERfoam for complex curve drapability, fast assembly Photo Credit: CW at JEC World 202 SAERTEX (Saerbeck, Germany) displayed a variety of products and applications. One of the more eye-catching displays was its SAERfoam-cored wind blade segment featuring its patent-pending “puzzle” pattern for drapability and improved assembly of precut kits. As explained in a June 2021 webinar, SAERfoam does not use a scrim, but instead inserts glass fibers into the foam for improved connection to sandwich skins. The drapable “puzzle” pattern enables conformability to complex curves, which facilitates dry layup for infusion and reduces resin consumption. Larger, dog bone-shaped pieces can be cut and used to quickly secure abutted foam pieces during dry layup. The cut pattern also aids with excellent resin flow and wetout during infusion. Hydrogen tanks proliferate CW has been writing about the impact of the green energy transition on composites, specifically the rapidly growing hydrogen economy’s need for compressed gas and cryogenic liquid hydrogen storage tanks and how that will affect the carbon fiber supply chain. Spoiler alert — the estimated need for millions of tanks by 2030 is already putting a strain on the supply of composite pressure vessels as well as the high-strength carbon fiber they require. Accordingly, hydrogen storage tanks were popular in JEC World 2022 displays: A Type IV compressed gas tank made by MIKROSAM using its automated towpreg winding system for H2storage.nl CW’s recent MIKROSAM webinar. Tank for H2storage.nl made by MIKROSAM using towpreg winding. Photo Credit: CW Type IV compressed gas tanks were displayed by Hanwha Solutions (Seoul, South Korea), which recently acquired composite tank manufacturer Cimarron Composites (Huntsville, Ala., U.S.). Photo Credit: CW Cutaway of Type IV compressed gas tank displayed by engineering firm CIKONI (Stuttgart, Germany) and fiber patch placement (FPP) technology supplier Cevotec (Unterhaching, Germany) in a project that has demonstrated at least 15% material savings by using FPP reinforcement on the tank boss dome to reduce redundant whole tank windings. Photo Credit: CW

New York, April 15, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global and China Industrial Laser Industry Report, 2020-2026" - With the continuous improvement of domestic economic conditions, China’s laser industry has been booming. In recent years, China has intensified the development of the laser industry, and all regions have concentrated on scientific research, technology upgrades, market exploration, and construction of laser industrial parks with laser companies under the leadership of the government. In 2019, the market size of China’s laser processing equipment hit RMB65.8 billion with the CAGR of 21.4% in 2012-2019. In the medium and long term, laser processing (laser cutting and welding) will penetrate into more application scenarios (3C, power batteries, photovoltaics, etc.). China’s laser processing market will maintain a rapid growth trend for a long time with potentials. Among application scenarios, laser cutting is gradually replacing traditional machine tools and is used in a wider range of fields due to its advantages such as non-contact with objects, zero cutting head wear, fast cutting speed, adaptability and flexibility, which can improve processing efficiency, reduce processing costs, and enhance workpiece quality. Common laser processing equipment includes: laser cutters, laser welders, laser markers, laser drilling machines, laser cladding equipment, etc.Laser cutting is the most important application segment of laser processing. The sales volume of laser cutters (optical fiber + CO2) in China swelled from 2,700 units in 2013 to 41,000 units in 2019. In terms of market size, Chinese laser cutting market valued RMB25.8 billion in 2019, accounting for 39% of Chinese laser equipment market. Wherein, 19% came from laser marking and only 12% from laser welding.In terms of the competitive landscape, the concentration of laser processing equipment in China is relatively low. In 2019, there were more than 150 domestic laser companies with the annual revenue of over RMB20 million, more than half of which focused on laser processing and laser-related fields. In 2019, Han’s Laser earned the revenue of RMB7.64 billion from laser processing equipment, with a market share of 12.6%; Huagong Tech’s laser processing equipment revenue reached RMB1.723 billion, occupying a market share of 2.8%.Lasers are the core optical components of laser equipment. The rapid growth of the downstream equipment market drives the demand for lasers. In 2019, China’s overall industrial laser market size (including laser amplifiers) hit RMB26.1 billion, with the CAGR of 18.1% in 2015-2019.By gain medium, lasers can be divided into solid-state lasers (including all-solid-state, fiber, hybrid and semiconductor lasers), gas lasers, liquid lasers, etc. Solid-state lasers (generally refer to all-solid-state lasers in a narrow sense) and fiber lasers are the two mainstream lasers on the current market, which enjoyed market share of 30.1% and 44.4%, respectively in 2019.In recent years, industrial lasers have been rapidly localized with descending prices. Take fiber lasers as an example, the localization rate of low-, medium-, and high-power fiber lasers in China reached 98.81%, 57.76%, and 55.56% in 2019 respectively. Correspondingly, the prices of fiber lasers at all power levels have slumped in the past 10 years. The average price of a 3000W fiber laser in China was RMB1.5 million in 2012, while it descended to only about RMB400,000 in 2018, and further dropped to about RMB250,000 in 2020.As for the competitive landscape, China industrial laser market is highly concentrated compared to the relatively fragmented market structure of laser equipment. In 2019, CR3 (IPG, Wuhan Raycus Fiber Laser Technologies, Maxphotonics) accounted for nearly 80% of the fiber laser market, of which IPG was far ahead with a share of 41.9% as a leader. The market share of domestic laser companies presented an upward trend. From 2017 to 2019, the market share of IPG declined year by year, from 53% to 42%. In contrast, the market share of Wuhan Raycus Fiber Laser Technologies jumped from 12% to 24%, and Maxphotonics’ market share increased from 10% to 12%.Global and China Industrial Laser Industry Report, 2020-2026 highlights the following:Industrial laser (classification, technical status, industry chain, etc.);Global industrial laser industry (development environment, market size, market structure, application status, competitive landscape, development tendency, etc.);China industrial laser industry (development environment, status quo, market size, market structure, competitive pattern, market price, development trend, etc.)Industrial laser market segments, e.g., CO2 laser, solid-state laser, fiber laser, semiconductor laser, UV laser (market size, market structure, competitive pattern, etc.);Upstream markets (gain medium, pump source, etc.); downstream laser processing equipment market (market size, major companies, market segment, applications, etc.);11 foreign and 15 Chinese industrial laser manufacturers (operation, industrial laser business, etc.).Read the full report: ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________